chrisvoncsefalvay/vaers-outcomes huggingface dataset:
24 hours post vaccination with Pneumovax23, patient felt onset of chills, fever (reported: did not take temp), foot spasms, bad taste in mouth, and whole-body weakness/fatigue. Took Nyquil and slept through night. Awoke 10/23/13 feeling better, except for pronounced local reaction at injection site (seen by RN: Visibly red, swollen from injection, site down to elbow, and hot to touch).  Has not sought medical care beyond reporting to local health dept.
Symptoms - ? EE reports she received her vaccine during work yesterday and then worked until approximately 8:00 PM.  EE reports arm soreness and pain at injection site.  EE reports she woke up around 04:00 with flu like symptoms, body aches (reporting so bad she is barely able to get out of bed), fever (Tmax 101.4).  + runny nose, congestion and headache.  EE reports + exposure to pt with only wearing surgical mask approx. 3 weeks, and was contacted by EH and was considered low-risk and not scheduled for testing.   Last day of work and shift - ? yesterday left work at approx. 8:00 PM Home remedies? -   Tylenol at 0700, 600 mg ibuprofen at 11:30 Any improvement? - none Recommendation? After completely algorithm, EE meets criteria to be COVID tested and removed from work at this time.  EE provided with EH command center and instructions to notify them need for COVID-19 testing.  EE educated to notify his manager.  EE verbalized back understanding and denied further questions at this time.
Itchiness at the injection site; welts at injection site; Red at the injection site; Bump at the injection site; Hot at injection site; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE VESICLES (Bump at the injection site), VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE PRURITUS (Itchiness at the injection site), VACCINATION SITE URTICARIA (welts at injection site) and VACCINATION SITE ERYTHEMA (Red at the injection site) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history provided).    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Jan-2021, the patient experienced VACCINATION SITE VESICLES (Bump at the injection site), VACCINATION SITE WARMTH (Hot at injection site) and VACCINATION SITE ERYTHEMA (Red at the injection site). On 11-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itchiness at the injection site) and VACCINATION SITE URTICARIA (welts at injection site). At the time of the report, VACCINATION SITE VESICLES (Bump at the injection site), VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE PRURITUS (Itchiness at the injection site), VACCINATION SITE URTICARIA (welts at injection site) and VACCINATION SITE ERYTHEMA (Red at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.; Reporter's Comments: This case concerns a 59-year-old female with a nonserious unexpected event of vaccination site vesicles, vaccination site warmth, and nonserious expected vaccination site urticaria, vaccination site pruritus, vaccination site erythema. Event onset the same day as first dose mRNA-1273. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Patient felt vaccine given too high on arm.  It hurt when given and continues to hurt.  She cannot lift arm over her head without pain
For the past 15 yrs, pt has had single spot zoster breakouts on her gluteal area approx every year. She received ZOSTAVAX 11-7-08. Since that time, breakout frequency has increased to every week. A spot will develop, last approx 7 days, heal then another spot appears in close proximity soon after. She experiences a severe burning pain with each outbreak, all with the same intensity. She admits to many stressors in her life during this time frame also.
Began running fever, coughing. Still has fever after 3 days. Temp ranging from 100.5 - 102.8. Have contacted doctor by phone, no action taken.
Started with SOB and palpitations. Foudn to have new congestive heart failure and arrhythmia.
This spontaneous report as received from a 68 year old female consumer refers to herself. The patient had no drug allergies. The patient had had nerve pain due to chemotherapy for colon cancer. On 29-JAN-2013, the patient was once vaccinated with live ZOSTAVAX (lot # not reported). Concomitant therapies included gabapentin. On 31-JAN-2013 (also reported as "31-JAN-2012"), the patient experienced nerve pain increased. The patient did not seek medical attention. No treatment was given. No lab diagnostics studies were performed. The outcome was unknown. Additional information has been requested.
Information has been received from a health professional concerning a female patient who on 04-MAY-2007 and in October 2007, was vaccinated with first dose and second dose of GARDASIL, respectively. Subsequently, the patient experienced abdominal pain. Unspecified medical attention was sought. No laboratory diagnostic studies were performed. At the time of this report, the patient had not recovered. No product quality complaint was involved. Additional information has been requested. 04/07/2008 Follow up information stated that there were no adverse symptoms. The office manager stated she called to ask about dosing at the time the patient sought treatment for an unrelated medical condition. Additional information is not expected.
Soreness and swelling under my left armpit. This reaction happened the next day in the morning. I did not put anything on it or take anything due to it not being really sore. I went in for a routine mammogram in March 2021 and  it was abnormal they found left enlarged lymph nodes in the left axilla. They had me follow up with an ultrasound which I received March 23, 2021 which found multiple axillary lymph nodes. Benign Axillary lymph nodes. No mass. They recommended routine screening of March 2022. The doctor did ask me where did I receive my vaccine shot I told her it was in my left arm. Doctor said they are seeing that these enlarged lymph nodes are happening in the same arm as the vaccination shot.
Left delotid swelling itching, local pain, area not hot.  Vaccine was administered on 13 Feb 04, approximately 0930 hrs.  Symptoms subsided until 21 Feb 04.  Member reports on 22 Feb 04 to inform clinic of reaction.  Member instructed to use benadryl as needed and return if symptoms persist.
First visit to physician. Normal EKG.  Received ER medical records. Death Certificate received on 12/01/2004 states pt experienced arteriosclerotic heart disease.
No adverse reaction - just received the J&J vaccine a second dose administered in error. First dose 6/7/2021 and the second 7/15/2021.
Patient passed out - patient laid on floor by nurses, legs put up, cold towel to head, pulse 80, BP 100/80.
MY DAUGHTER WAS ADMINISTERED THE HPV VAC SEPT. 23RD WITH A FLU SHOT AND THEN WAS GIVEN THE DEPO AND ANOTHER HPV VACCINATION 1 WEEK LATER, OCT. 10TH. PATIENT FAINTED AFTER DRIVING HERSELF TO WORK AND IS HAVING DIFFERENT SIDE EFFECTS. TROUBLE WITH RIGHT EYE, BLURRY VISION, EYELID NOT OPENING, MIGRAINES, CONSTIPATION, WEIGHT LOSS, LOSS OF APPETITE, CHEMICAL/BLEACH TASTE IN MOUTH, RASH ON FACE, HAIR LOSS, FATIGUE. PATIENT IS VERY PETITE AND ONLY WEIGHED 90LBS TO START AND NOW WEIGHS 85LBS. PATIENT WAS NOT SUPPOSE TO BE GIVEN THE HPV/GARDISIL VAC. HER DR. IS NOW DENYING THE 2ND WAS GIVEN TO HER, BUT PATIENT WAS GIVEN A SHOT IN EACH ARM AND OUR INSURANCE WAS BILLED. HELP!
Tiredness (exhausted), Light headed (thought I was going to pass out), fever 102, shivering, nausea, dizziness,  My arm was very very red and lots of heat (fever).  Slept totally first day, fever broke about 36 hours later after the symptoms started on 5/28/20.  Fever and redness in arm lasted almost a week.  I literally slept for almost 4 days.  Took a week to get my strength back.
Is a male who does have a history of having to straight cath  himself on a regular basis to get urine and states that he has not been able to get any urine return in about 48 hours.  Apparently at the nursing facility they attempted to place a catheter but were unsuccessful.  Patient denies any abdominal discomfort nausea vomiting fevers chills back pain or any other complaints at this time.  He does see Dr. with urology.  He states he has a "hard bladder."
Information has been received from a physician concerning a female long-term nursing facility pt who was vaccinated with the 1st dose of Hep-B vaccine and within a few minutes, post vax, the pt experienced dizziness and "syncope" which lasted for approx. 30 minutes. The pt sought unspecified medical attention. No further information is available.
Shoulder sore. Pain in forearm and hand. Applied ice packs. Took Ibuprofen.
Patient had no adverse event, just reporting due RN giving the vaccine IM instead of subcutaneously. RN called CDC for recommendations and it was not recommended to repeat dose.
Dtap was mixed with proquad and given to patient. Patient had no adverse event or signs or symptoms. CDC recommended waiting 28 days to repeat live vaccines and repeating the other one now.
p/vax pt devel generalized aching & felt warm. pt felt electric shock pain just below the replaced (left knee) joint, pain was described as almost tingling & numb.treated w/heat & cold.
Soreness, swelling and redness at injection site. About 10 hours after the injection intense shivering, fever, and headache.
Patient had a first dose of MODERNA Covid-19 vaccine administered on 06/25/21. Patient came into the pharmacy for second dose of MODERNA and was given a dose of Pfizer vaccine by mistake. No adverse effects are reported at this time.
This is a spontaneous report received from a non-contactable reporter(s) (consumer or other non-HCP) from Regulatory Authority. The reporter is the patient. A female patient received BNT162B2 (COMIRNATY, solution for injection) (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunisation. Relevant medical history included: "liver and kidney failure" (unspecified if ongoing); "Kidney failure" (unspecified if ongoing); "No immune system" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: ARTHRALGIA (non-serious), outcome "unknown", described as "soreness in her shoulder"; NECK PAIN (non-serious), BONE PAIN (non-serious), outcome "unknown" and all described as "soreness in her shoulder and neck bone". The lot number for BNT162B2, was not provided and will be requested during follow up.
03/07/21: Onset of dyspnea upon exertion 03/09/21: Worsening dyspnea and non-productive cough 03/11/21: Primary care visit for diagnosis/tests 03/12/21: Elevated BNP levels noted; chest X-ray 03/13/21: Further worsening of dyspnea 03/15/21: D Dimer test elevated (positive) 03/15/21: ED visit; CTA scan indicates pulmonary emboli (lots of clots); admitted to hospital; Heparin IV drip 03/16/21: (evening) Discharge on Eliquis 03/17/21: Moderately severe dyspnea upon exertion and non-productive cough continues Event: Pulmonary emboli
Low grade Fever, headache needing admission Intracranial hemorrhage with hypertension  Medical management for hypertensive emergency Received surgical evacuation admitted in Intensive care,
no adverse effects; vaccinated with one dose of improperly stored PROQUAD; This spontaneous report was received from a nurse referring to a 4-year-old child patient of unknown gender. The patient's concurrent conditions, medical history and drug reactions/allergies were not reported. Concomitant medication included sterile diluent. On 25-JUL-2019, the patient was vaccinated with one dose of improperly stored Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) lot/batch # R030803 and expiry date: 22-APR-2020 reconstituted with properly stored diluent for prophylaxis (strength, dose, unit, route and anatomical location were not reported) (product storage error). No adverse effects were reported. The administered dose of vaccine experienced temperature excursion from 6ºF to 14ºF for a time frame of 24 hours. No previous temperature excursion occurred. The call was due to digital data logger. The outcome of the product storage error was unknown.
Information has been received from a medical assistant concerning a female patient who on unspecified date was vaccinated PNEUMOVAX 23  (Lot : 662661/0978X). The patient was seen in the office approximately on 28-MAY-2009 (reported as last week) with a diagnosis cellulitis. The patient was treated with KEFLEX and ibuprofen. At the time of reporting the patient's present status was unknown. This is one of two reports from the same source. Additional information has been requested.
chest discomfort; shortness of breath; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (chest discomfort) and DYSPNOEA (shortness of breath) in an 82-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 001B21A) for COVID-19 vaccination.     Concurrent medical conditions included Coronary disease.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form once. On 10-Apr-2021, the patient experienced CHEST DISCOMFORT (chest discomfort) and DYSPNOEA (shortness of breath). At the time of the report, CHEST DISCOMFORT (chest discomfort) and DYSPNOEA (shortness of breath) had not resolved.            Concomitant medications were not provided. Treatment information was not reported.
ED note by Dr. on 1/8/22: "Chief Complaint:  Abdominal Pain   HISTORY OF PRESENT ILLNESS   Patient, is a 13 y.o.male who presents to the Emergency Department with right lower quadrant abdominal pain onset yesterday morning. Patient notes that his pain initially was intermittent, but in the past few hours have become constant. Patient states that his pain is exacerbated after eating. The patient denies measured fevers, nausea, vomiting, diarrhea, shortness of breath, chest pain or extremity pain.    REVIEW OF SYSTEMS   The pertinent positive and negative symptoms are as per HPI. All other systems reviewed and are negative." "Encounter Diagnosis Name Primary? ? Acute appendicitis Yes   DISPOSITION/PLAN   Admitted     Condition at Disposition: Fair "  H&P note by Dr. on 1/9/22: "Patient Name:   Patient MRN:   Patient DOB:   Date of Service:1/9/2022   CC:  Chief Complaint Patient presents with ? Abdominal Pain     HPI: 13 yo male presented to the ER department last night with a 36 hour history of RLQ abdominal pain.  He states it was very mild on Friday night but became intolerable last evening.  Some nausea.  +Leukocytosis 15k.  CT shows acute appendicitis with fecaliths, pelvic fluid and retrocecal appendix.  He was started on IV antibiotics and admitted for appendectomy.  He is Positive for COVID 19.  Had both vaccinations this past summer.    History reviewed. No pertinent past medical history." "ASSESSMENT: 13 y.o. male with acute appendicitis, retrocecal appendix, Covid 19.   PLAN: 1. OR for laparoscopic appendectomy, possible open 2. Risk of infection/abscess, hernia, bleeding, iatrogenic intraabdominal injury"
Invalid vaccine type administered; Pink Capped COVID-19 vaccine given instead of Blue Capped COVID-19 vaccine.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Pharmacist).  A 51 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 11Jan2021 (Batch/Lot number: unknown) at the age of 49 years as dose 2, single and administration date 21Dec2020 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "calculus of kidney" (unspecified if ongoing); "hyperlipidemia" (unspecified if ongoing); "type 2 diabetes" (unspecified if ongoing), notes: type 2 diabetes; "depression" (unspecified if ongoing); "vertigo" (unspecified if ongoing). Concomitant medication(s) included: MECLIZINE [MECLOZINE]; METFORMIN XR; MORPHINE; GABAPENTIN; OMEPRAZOLE; FLUOXETINE; OXCARBAZEPINE. Past drug history included: Hydrocodone, reaction(s): "Known allergies: hydrocodone". The following information was reported: DRUG INEFFECTIVE (medically significant) with onset 12Mar2022, outcome "unknown", COVID-19 (medically significant) with onset 12Mar2022, outcome "recovered" (14Mar2022) and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
after 3 days from the first injection diarrhea lasting 72 hours and resulting in 10  lbs weight loss after 2 days from the second shot same result ...took Imodium and it finally stopped
feels she had COVID-19; like a bee sting at the injection site; swelling in arm at the injection site; Dizziness; arm like a hard boiled egg, at the injection site; vertigo only when standing to lay down; warmness at the injection site; arm was a little sore; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (feels she had COVID-19), VERTIGO (vertigo only when standing to lay down), VACCINATION SITE WARMTH (warmness at the injection site), PAIN IN EXTREMITY (arm was a little sore) and DIZZINESS (Dizziness) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M208 and 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure, Autoimmune disorder, Thyroid disorder and Neuropathy. Concomitant products included PREDNISONE for Autoimmune disorder, ATENOLOL for Blood pressure, GABAPENTIN (NEURONTIN) for Neuropathy, LIOTHYRONINE SODIUM (CYTOMEL) for Thyroid disorder.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm was a little sore). On 16-Mar-2021, the patient experienced VERTIGO (vertigo only when standing to lay down), VACCINATION SITE WARMTH (warmness at the injection site), DIZZINESS (Dizziness), VACCINATION SITE INDURATION (arm like a hard boiled egg, at the injection site) and VACCINATION SITE SWELLING (swelling in arm at the injection site). On an unknown date, the patient experienced SUSPECTED COVID-19 (feels she had COVID-19) and VACCINATION SITE PAIN (like a bee sting at the injection site). The patient was treated with MECLIZINE [MECLOZINE] for Vertigo and Dizziness, at an unspecified dose and frequency. At the time of the report, SUSPECTED COVID-19 (feels she had COVID-19), VERTIGO (vertigo only when standing to lay down), VACCINATION SITE WARMTH (warmness at the injection site), PAIN IN EXTREMITY (arm was a little sore), DIZZINESS (Dizziness), VACCINATION SITE INDURATION (arm like a hard boiled egg, at the injection site), VACCINATION SITE PAIN (like a bee sting at the injection site) and VACCINATION SITE SWELLING (swelling in arm at the injection site) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment included meclezine for dizziness and vertigo   This case was linked to MOD-2021-103706 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Reporter details, concomitant medications, second dose vaccine details and new events were added.
Patient developed mild itching and "knot" in throat, superficial red bumps to upper right arm near vaccination site. Patient was given 2 cups of water and symptoms resolved soon after.
tiredness/ fatigue; muscle ache; This case was reported by a pharmacist via call center representative and described the occurrence of tiredness in an unspecified number of patient's who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced tiredness and muscle pain. On an unknown date, the outcome of the tiredness and muscle pain were unknown.   It was unknown if the reporter considered the tiredness and muscle pain to be related to Shingrix.  Additional details were provided as follows: The reporter stated that 20 to 30 percent of their patients have the common side effects of tiredness, fatigue and muscle ache post vaccination. The reporter consented to follow up. This case is linked to case US2020007421 reported by the same reporter for different patient.
Patient was given an MMR vaccine at 2 months of age.  Patient is fine at this point.
Within 1 hour after getting her MENACTRA she had a severe headache, nauseated, dizzy, felt like she was going to pass out. Vomited on day 2, 7/18/18. Started feeling better on 7/19/18.
CHILLS; FEVER; HEADACHE; MUSCLE ACHES; INJECTION SITE PAIN; This spontaneous report received from a patient concerned a 48 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: UNKNOWN) dose was not reported, administered on 11-APR-2021 15:20 for prophylactic vaccination. No concomitant medications were reported. On 11-APR-2021, the subject experienced injection site arm pain. On 12-APR-2021, the subject experienced chills. On 12-APR-2021, the subject experienced fever. On 12-APR-2021, the subject experienced headache. On 12-APR-2021, the subject experienced muscle aches. Laboratory data included: Body temperature (NR: not provided) 101 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, chills, headache, muscle aches, and injection site arm pain. This report was non-serious.
Prior I had a UTI (undiagnosed a the time), then since taking the vaccine slightly over 24 hours later, I got severe lower left abdominal pain. I was admitted to the hospital with the severe pain, chills, fever. After a CT scan it was determined I had an inflamed bladder with severe bladder spasms.
Intranasal Flu Mist given to Pregnant Teen.  No immediate adverse effects. Advised client to inform medical provider ASAP.
no side effects after shot other than sore arm until 8 days later when the injection site became red, warm and a little swollen. Appears less red today than yesterday but still warm and swollen. No other symptoms and feeling healthy otherwise.
DVT in right leg 4 days after injection, severe pain in thigh/calf, difficulty walking  Placed on Xarelto 15mg 2X daily for 21 days and then 20mg daily for 9 days. Next Doctor visit is 1/26/2021 at 9:00am Next scheduled Covid 19 vaccine is scheduled for 2/5/2021 at 7:15am